Germing U - Search Results

1

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.

Oosterveld M, Suciu S, Muus P, Germing U, Delforge M, Belhabri A, Aul C, Selleslag D, Ferrant A, Marie JP, Amadori S, Jehn U, Mandelli F, Hess U, Hellström-Lindberg E, Cakmak-Wollgast S, Vignetti M, Labar B, Willemze R, de Witte T. Oosterveld M, et al. Among authors: germing u. Ann Hematol. 2015 Jan;94(1):23-34. doi: 10.1007/s00277-014-2177-y. Epub 2014 Aug 7. Ann Hematol. 2015. PMID: 25096636

2

[Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].

Jaeger M, Aul C, Söhngen D, Germing U, Schneider W. Jaeger M, et al. Among authors: germing u. Beitr Infusionsther. 1992;30:464-8. Beitr Infusionsther. 1992. PMID: 1284762 German.

3

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

4

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

5

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

6

Serum deoxythymidine kinase in myelodysplastic syndromes.

Aul C, Gattermann N, Germing U, Winkelmann M, Heyll A, Runde V, Schneider W. Aul C, et al. Among authors: germing u. Cancer. 1994 Jan 15;73(2):322-7. doi: 10.1002/1097-0142(19940115)73:2<322::aid-cncr2820730215>3.0.co;2-e. Cancer. 1994. PMID: 8293395

7

[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1996 Sep 13;121(37):1113-8. doi: 10.1055/s-2008-1043114. Dtsch Med Wochenschr. 1996. PMID: 8925725 German.

8

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

9

Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.

Meckenstock G, Aul C, Hildebrandt B, Heyll A, Germing U, Wehmeier A, Giagounidis A, Suedhoff T, Burk M, Soehngen D, Schneider W. Meckenstock G, et al. Among authors: germing u. Leuk Lymphoma. 1998 May;29(5-6):523-31. doi: 10.3109/10428199809050912. Leuk Lymphoma. 1998. PMID: 9643566

10

Problems in the classification of CMML--dysplastic versus proliferative type.

Germing U, Gattermann N, Minning H, Heyll A, Aul C. Germing U, et al. Leuk Res. 1998 Oct;22(10):871-8. doi: 10.1016/s0145-2126(97)00192-6. Leuk Res. 1998. PMID: 9766745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page